Age and baseline values predict 12 and 24-month functional changes in type 2 SMA

Neuromuscul Disord. 2020 Sep;30(9):756-764. doi: 10.1016/j.nmd.2020.07.005. Epub 2020 Jul 25.

Abstract

The aim of this retrospective study was to establish the range of functional changes at 12 and 24-month in 267 type 2 Spinal Muscular Atrophy (SMA) patients with multiple assessments. We included 652 Hammersmith Functional Motor Scale Expanded (HFMSE) assessments at 12 month- and 305 at 24 month- intervals. The cohort was subdivided by functional level, Survival of Motor Neuron copy number and age. Stable scores (± 2 points) were found in 68% at 12 months and in 55% at 24 months. A decrease ≥2 points was found in 21% at 12 months and in 35% at 24 months. An increase ≥2 points was found in 11% at 12 months and 9.5% at 24 months. The risk of losing ≥2 points increased with age and HFMSE score at baseline both at 12 and 24-month. For each additional HFMSE point at baseline, the relative risk of a >2 point decline at 12 months increases by 5% before age 5 years (p = 0.023), by 8% between 5 and 13 (p<0.001) and by 26% after 13 years (p = 0.003). The combination of age and HFMSE scores at baseline increased the ability to predict progression in type 2 SMA.

Keywords: Hammersmith functional motor scale expanded; Neuromuscular disorders; Outcome measures; Spinal muscular atrophy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Disease Progression
  • Female
  • Humans
  • Male
  • Muscular Atrophy, Spinal / physiopathology*
  • Oligonucleotides / blood
  • Retrospective Studies
  • Spinal Muscular Atrophies of Childhood / physiopathology*

Substances

  • Oligonucleotides